P53

Subtle sequence changes determine whether a common gene regulatory sequence acts as an ‘on’ or ‘off’ switch

Cancer-suppressor protein p53 has undergone dramatic shifts in understanding over the past 30 years, but now scientists are entering a new era in the development of novel p53-based therapies.